Form D Explorer

Form C-AR — FibroBiologics, Inc.

0001193125-23-130251 · filed 2023-05-01

Offering

Target: —
Maximum: —
Security type: —
Price per security: —
Deadline: —
Oversubscription: —

Issuer

Name: FibroBiologics, Inc.
CIK: 1958777
Entity: Corporation
Jurisdiction: DELAWARE
Address: 455 E. MEDICAL CENTER BLVD, SUITE 300
HOUSTON, TX 77598
Phone: 281 671-5150

Most recent fiscal year financials

Total assets

$4,824,000

Cash

—

Short-term debt

$7,073,000

Long-term debt

$1,747,000

Revenues

—

COGS

—

Taxes paid

—

Net income

$-5,121,000

Same issuer's Form D filings

D · 2025-12-16

$1.7M
D · 2025-12-03

$4M
D · 2025-12-03

$1.5M

View original on SEC EDGAR.